TNFSF10 and leukemia: A research study has shown that quercetin combined with a recombinant ligand affecting apoptosis, such as TNF-related apoptosis-inducing ligand (TRAIL), or anti-CD95, could sensitize several leukemia cell lines and B cells isolated from patients with B-CLL.